EPIZYME
Epizyme is a biopharmaceutical company located in Cambridge, MA, that is focused on researching treatments for blood cancer and tumors. Founded in late 2007, the company has brought together premier academic and industry leaders to rapidly translate the exciting discoveries emerging from epigenetic research into specific programs that will produce important, novel, molecularly targeted drugs of the future.
EPIZYME
Industry:
Biopharma Biotechnology Health Care
Founded:
2007-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.epizyme.com
Total Employee:
101+
Status:
Active
Contact:
1(617)349-0707
Email Addresses:
[email protected]
Total Funding:
834.08 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon WordPress Content Delivery Network Google Universal Analytics
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Frazier Healthcare Partners
Frazier Healthcare Partners investment in Post-IPO Equity - Epizyme
Royalty Pharma
Royalty Pharma investment in Post-IPO Equity - Epizyme
Celgene
Celgene investment in Post-IPO Equity - Epizyme
GlaxoSmithKline
GlaxoSmithKline investment in Venture Round - Epizyme
Leukemia & Lymphoma Society
Leukemia & Lymphoma Society investment in Venture Round - Epizyme
Multiple Myeloma Research Foundation
Multiple Myeloma Research Foundation investment in Grant - Epizyme
New Enterprise Associates
New Enterprise Associates investment in Series B - Epizyme
Kleiner Perkins
Kleiner Perkins investment in Series B - Epizyme
Astellas Venture Management
Astellas Venture Management investment in Series B - Epizyme
Amgen Ventures
Amgen Ventures investment in Series B - Epizyme
Key Employee Changes
| Date | New article |
|---|---|
| 2022-03-15 | Epizyme Announces Executive Appointment and Provides Tazemetostat Clinical Update |
| 2021-08-09 | Epizyme Announces CEO Succession |
| 2020-03-23 | Epizyme Names Infinity’s Jeffery Kutok as Chief Scientific Officer |
Official Site Inspections
http://www.epizyme.com Semrush global rank: 7.1 M Semrush visits lastest month: 594
- Host name: a4ec4c6ea1c92e2e6.awsglobalaccelerator.com
- IP address: 15.197.142.173
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Epizyme"
Organization | Epizyme, Inc.
Epizyme, Inc. Report issue Contributed to NMEFor profit Phase 1 Phase 2 Phase 3 Founded: Cambridge MA United States (2007) Status: Acquired by Ipsen (2022) Organization Overview …See details»
EIN 26-1349956 - Epizyme, Inc., Cambridge, Massachusetts
Epizyme, Inc. is a corporation in Cambridge, Massachusetts. The employer identification number (EIN) for Epizyme, Inc. is 261349956. EIN for organizations is sometimes also referred to as …See details»
Epizyme - Leadership Team | The Org
The Leadership Team at Epizyme plays a pivotal role in steering the company’s strategic direction and operational execution. Comprised of executives from diverse specialties, including scientific …See details»
Grant Bogle - President & CEO at Epizyme | The Org
Grant Bogle joined Epizyme in August 2021 as President and Chief Executive Officer and has served on the Epizyme board of directors since September 2019. Prior to joining Epizyme, Grant served …See details»
Organizational Culture for Epizyme Inc - 247caseanalysis.com
Introduction Epizyme Inc is a large scnale company with many employees; the company treats its employees as an asset. The aim of the Epizyme Inc organisational culture is to create a positive …See details»
Epizyme Hires Former Sanofi Exec as Chief Operating Officer
May 6, 2016 Epizyme a clinical stage biopharmaceutical company creating novel epigenetic therapies for people with cancer, has expanded its senior leadership team with the addition of …See details»
Epizyme Announces CEO Succession - Nasdaq
Aug 9, 2021 Epizyme, Inc., a fully integrated, commercial-stage biopharmaceutical company developing and delivering novel epigenetic therapies today announced its Chief Executive Officer …See details»
Epizyme Technical Information | Epizyme
Protease 388,000 USP units Amylase 460,000 USP units Description: Epizyme is activated whole raw pancreas; a pancreatic enzyme concentrate of porcine origin …See details»
Ipsen completes acquisition of Epizyme expanding its …
Aug 12, 2022 Epizyme now operates as ‘an Ipsen company’ at deal close. As part of the transaction, Ipsen acquires Epizyme’s lead medicine, Tazverik ® …See details»
Ipsen completes acquisition of Epizyme expanding its portfolio in …
Ipsen also acquires Epizyme’s first-in-class, oral SETD2 inhibitor development candidate, EZM0414, which was granted FDA Fast Track status in 2021 and is currently under evaluation in a recently …See details»
Epizyme Announces CEO Succession - BioSpace
Aug 9, 2021 Epizyme, Inc., a fully integrated, commercial-stage biopharmaceutical company developing and delivering novel epigenetic therapies announced its Chief Executive Officer …See details»
Epizyme, Inc. Sustainability Report | DitchCarbon
Epizyme, Inc., headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of …See details»
Epizyme (DN4MDK8MKSZ6)
Epizyme (UEI DN4MDK8MKSZ6, CAGE 61Q34) based in Cambridge MA federal contracts, grants, registrations, vehicles, partnerships, and analysisSee details»
Founded On Research That...'Brought The House Down'
Apr 15, 2011 Epizyme was cofounded by Dr. Horvitz and Yi Zhang, Ph.D., whose description of his HMT research “brought the house down” at the 2007 retreat of MPM Capital’s medical and …See details»
David Loew on acquisition of Epizyme - United States
Aug 12, 2022 Epizyme welcome to Ipsen. Hear what CEO David Loew has to say about the official close of its acquisition of Epizyme.See details»
Epizyme: Plying the Epigenome's Enzymes: Chemistry & Biology
Apr 22, 2011 Epizyme got its start in mid 2008 and is among the first biotechnology companies with its sole focus on exploiting epigenetic discoveries to develop new medicines. Broadly, epigenetics …See details»
Epizyme - The Org
Epizyme, Inc. is a clinical-stage biopharmaceutical company. The Company discovers, develops, and plans to commercialize epigenetic therapies for cancer patients.See details»
Epizyme Inc Company Profile - Epizyme Inc Overview - GlobalData
Up-to-date Epizyme Inc company overview including funding information, company profile, key statistics, peer comparison and more.See details»
Epizyme Announces CEO Succession - Business Wire
Aug 9, 2021 Epizyme, Inc. is a fully integrated, commercial-stage biopharmaceutical company committed to its mission of rewriting treatment for cancer and other serious diseases through …See details»
Epizyme Company Profile - Office Locations, Competitors ... - Craft
Aug 4, 2022 Epizyme has 5 employees at their 1 location and $37.43 m in annual revenue in FY 2021. See insights on Epizyme including office locations, competitors, revenue, financials, …See details»